Salvage Surgery for Local Control of Brain Metastases After Previous Stereotactic Radiosurgery: A Single-Center Series
| Autor: | Manish K. Aghi, Aaron Gallagher, Daniel Cummins, Michael W. McDermott, Vivek Sudhakar, Satvir Saggi, Miguel M. Chavez, Jason E. Chung, Steve Braunstein, Lauro N. Avalos, Mariza Daras, Philip V. Theodosopoulos, Ramin A. Morshed |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Salvage Therapy
medicine.medical_specialty Multivariate analysis Brain Neoplasms business.industry medicine.medical_treatment Brachytherapy Radiosurgery Single Center Malignancy medicine.disease Surgery Treatment Outcome Tumor progression medicine Humans Neurology (clinical) business Adjuvant Retrospective Studies Brain metastasis |
| Zdroj: | World Neurosurgery. 158:e323-e333 |
| ISSN: | 1878-8750 |
| Popis: | Although overall survival (OS) has improved in patients with brain metastases (BMs), control of recurrent BMs remains a therapeutic challenge. Salvage surgery may achieve acceptable control rates in the setting of progression after previous stereotactic radiosurgery (SRS), yet it remains a question how additional adjuvant therapies may affect outcomes and how patient selection for salvage surgery may be optimized.Patients receiving salvage surgery for BM progression after previous SRS were retrospectively reviewed from a single center. Outcomes of interest included local tumor progression, leptomeningeal dissemination, and OS. Cox proportional hazard models and nominal logistic regression were applied to determine factors associated with outcomes of interest.A total of 43 patients with 50 BMs were included. After salvage surgery, local progression was observed for 17 BMs (34%), leptomeningeal dissemination was observed in 17 patients (39.5%), and censored median OS was 17.9 months. On multivariate analysis, use of brachytherapy was associated with improved local control (hazard ratio [HR], 0.15; 95% confidence interval [CI], 0.04-0.6; P = 0.008). For patients treated with SRS ≥4.5 months before salvage surgery, both brachytherapy (HR, 0.07; 95% CI, 0.01-0.39; P = 0.002) and postoperative adjuvant SRS (HR, 0.14; 95% CI, 0.02-1.00; P = 0.05) were associated with improved local control compared with no adjuvant radiation therapy. Presence of extracranial malignancy (HR, 6.70; 95% CI, 2.58-17.42; P0.0001) was associated with shorter survival. Graded prognostic assessment underestimated survival in 79.1% of patients, with a mean difference of 18.9 months between graded prognostic assessment-estimated and actual OS.In properly selected patients, salvage surgery may be an appropriate therapy for BM progression after previous SRS. Adjuvant brachytherapy and repeat SRS can offer significant benefit for local control with salvage resection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect